4//SEC Filing
Walker Karen Marie 4
Accession 0001193125-25-323332
CIK 0001994702other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:30 PM ET
Size
8.5 KB
Accession
0001193125-25-323332
Insider Transaction Report
Form 4
Walker Karen Marie
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-15$4.83/sh+23,998$115,910→ 46,634 total - Sale
Common Stock
2025-12-15$12.20/sh−23,998$292,776→ 22,636 total - Exercise/Conversion
Stock option (right to buy)
2025-12-15−23,998→ 85,865 totalExercise: $4.83Exp: 2033-11-05→ Common Stock (23,998 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.
- [F2]25% of the original number of shares subject to the option vested on January 1, 2025, and 1/48th of the original number of shares subject to the option vests in monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0002008556
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:30 PM ET
- Size
- 8.5 KB